BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9515801)

  • 21. Regulation of phosphorylation of deoxycytidine and 2',2'-difluorodeoxycytidine (gemcitabine); effects of cytidine 5'-triphosphate and uridine 5'-triphosphate in relation to chemosensitivity for 2',2'-difluorodeoxycytidine.
    van Haperen VW; Veerman G; Vermorken JB; Pinedo HM; Peters G
    Biochem Pharmacol; 1996 Apr; 51(7):911-8. PubMed ID: 8651941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similar changes were induced by Cladribine and by gemcitabine, in the deoxypyrimidine salvage, during short-term treatments.
    Csapó Z; Keszler G; Sasvári-Székely M; Smid K; Noordhuis P; Peters GJ; Staub M
    Adv Exp Med Biol; 1998; 431():525-9. PubMed ID: 9598122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.
    Bergman AM; Munch-Petersen B; Jensen PB; Sehested M; Veerman G; Voorn DA; Smid K; Pinedo HM; Peters GJ
    Biochem Pharmacol; 2001 Jun; 61(11):1401-8. PubMed ID: 11331076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant.
    Bergman AM; Eijk PP; Ruiz van Haperen VW; Smid K; Veerman G; Hubeek I; van den Ijssel P; Ylstra B; Peters GJ
    Cancer Res; 2005 Oct; 65(20):9510-6. PubMed ID: 16230416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine.
    Vande Voorde J; Sabuncuoğlu S; Noppen S; Hofer A; Ranjbarian F; Fieuws S; Balzarini J; Liekens S
    J Biol Chem; 2014 May; 289(19):13054-65. PubMed ID: 24668817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular targets of antitumor 2'-deoxycytidine analogues.
    Obata T; Endo Y; Murata D; Sakamoto K; Sasaki T
    Curr Drug Targets; 2003 May; 4(4):305-13. PubMed ID: 12699351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nucleoside kinases and new types of antitumor nucleosides].
    Matsuda A
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1594-9. PubMed ID: 9309159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity to gemcitabine and its metabolizing enzymes in neuroblastoma.
    Ogawa M; Hori H; Ohta T; Onozato K; Miyahara M; Komada Y
    Clin Cancer Res; 2005 May; 11(9):3485-93. PubMed ID: 15867251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo radiation sensitization by the halogenated pyrimidine 5-chloro-2'-deoxycytidine.
    Russell KJ; Rice GC; Brown JM
    Cancer Res; 1986 Jun; 46(6):2883-7. PubMed ID: 3698014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4).
    Townsend A; Leclerc JM; Dutschman G; Cooney D; Cheng YC
    Cancer Res; 1985 Aug; 45(8):3522-8. PubMed ID: 2410096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of enantiospecificity of human 2'-deoxycytidine kinase: relevance for the activation of beta-L-deoxycytidine analogs as antineoplastic and antiviral agents.
    Verri A; Focher F; Priori G; Gosselin G; Imbach JL; Capobianco M; Garbesi A; Spadari S
    Mol Pharmacol; 1997 Jan; 51(1):132-8. PubMed ID: 9016355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenomics of gemcitabine metabolism: functional analysis of genetic variants in cytidine deaminase and deoxycytidine kinase.
    Baker JA; Wickremsinhe ER; Li CH; Oluyedun OA; Dantzig AH; Hall SD; Qian YW; Ring BJ; Wrighton SA; Guo Y
    Drug Metab Dispos; 2013 Mar; 41(3):541-5. PubMed ID: 23230131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
    Mekras JA; Boothman DA; Perez LM; Greer S
    Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative.
    Yamagami K; Fujii A; Arita M; Okumoto T; Sakata S; Matsuda A; Ueda T; Sasaki T
    Cancer Res; 1991 May; 51(9):2319-23. PubMed ID: 2015596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiproliferative activity and mechanism of action of fatty acid derivatives of gemcitabine in leukemia and solid tumor cell lines and in human xenografts.
    Bergman AM; Kuiper CM; Noordhuis P; Smid K; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Fodstad O; Breistøl K; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1329-33. PubMed ID: 15571253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2',3'-didehydro-2',3'-dideoxy-5-chlorocytidine is a selective anti-retrovirus agent.
    Balzarini J; Van Aerschot A; Herdewijn P; De Clercq E
    Biochem Biophys Res Commun; 1989 Nov; 164(3):1190-7. PubMed ID: 2590197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N3 and O2 protonated tautomeric conformations of 2'-deoxycytidine and cytidine coexist in the gas phase.
    Wu RR; Yang B; Frieler CE; Berden G; Oomens J; Rodgers MT
    J Phys Chem B; 2015 May; 119(18):5773-84. PubMed ID: 25874502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity.
    Kroep JR; Loves WJ; van der Wilt CL; Alvarez E; Talianidis I; Boven E; Braakhuis BJ; van Groeningen CJ; Pinedo HM; Peters GJ
    Mol Cancer Ther; 2002 Apr; 1(6):371-6. PubMed ID: 12477049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic activity of gemcitabine and correlation with expression profile of drug-related genes in human lymphoid cells.
    Giovannetti E; Mey V; Loni L; Nannizzi S; Barsanti G; Savarino G; Ricciardi S; Del Tacca M; Danesi R
    Pharmacol Res; 2007 Apr; 55(4):343-9. PubMed ID: 17296311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines.
    Gourdeau H; Clarke ML; Ouellet F; Mowles D; Selner M; Richard A; Lee N; Mackey JR; Young JD; Jolivet J; Lafrenière RG; Cass CE
    Cancer Res; 2001 Oct; 61(19):7217-24. PubMed ID: 11585758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.